BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24047545)

  • 21. Symptom validity assessment: practice issues and medical necessity NAN policy & planning committee.
    Bush SS; Ruff RM; Tröster AI; Barth JT; Koffler SP; Pliskin NH; Reynolds CR; Silver CH
    Arch Clin Neuropsychol; 2005 Jun; 20(4):419-26. PubMed ID: 15896556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidimensional Malingering Criteria for Neuropsychological Assessment: A 20-Year Update of the Malingered Neuropsychological Dysfunction Criteria.
    Sherman EMS; Slick DJ; Iverson GL
    Arch Clin Neuropsychol; 2020 Aug; 35(6):735-764. PubMed ID: 32377667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom validity testing, effort, and neuropsychological assessment.
    Bigler ED
    J Int Neuropsychol Soc; 2012 Jul; 18(4):632-40. PubMed ID: 23057080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embedded performance validity testing in neuropsychological assessment: Potential clinical tools.
    Rickards TA; Cranston CC; Touradji P; Bechtold KT
    Appl Neuropsychol Adult; 2018; 25(3):219-230. PubMed ID: 28139144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malingering assessment: evaluation of validity of performance.
    Vanderploeg RD; Curtiss G
    NeuroRehabilitation; 2001; 16(4):245-51. PubMed ID: 11790911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical myths of forensic neuropsychology.
    Greiffenstein MF
    Clin Neuropsychol; 2009 Feb; 23(2):286-96. PubMed ID: 18609338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index and stand-alone symptom validity tests in a military sample.
    Armistead-Jehle P; Hansen CL
    Arch Clin Neuropsychol; 2011 Nov; 26(7):592-601. PubMed ID: 21672936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical issues associated with the assessment of exaggeration, poor effort, and malingering.
    Iverson GL
    Appl Neuropsychol; 2006; 13(2):77-90. PubMed ID: 17009881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity testing and neuropsychology practice in the VA healthcare system: results from recent practitioner survey (.).
    Young JC; Roper BL; Arentsen TJ
    Clin Neuropsychol; 2016 May; 30(4):497-514. PubMed ID: 27032437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom validity testing: a critical review.
    Bianchini KJ; Mathias CW; Greve KW
    Clin Neuropsychol; 2001 Feb; 15(1):19-45. PubMed ID: 11778576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the predictive value of the Test of Memory Malingering: an illustrative example for clinicians.
    O'Bryant SE; Lucas JA
    Clin Neuropsychol; 2006 Sep; 20(3):533-40. PubMed ID: 16895864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of performance and symptom validity testing with pediatric populations.
    Kirk JW; Baker DA; Kirk JJ; MacAllister WS
    Appl Neuropsychol Child; 2020; 9(4):292-306. PubMed ID: 32372667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Test of memory malingering (TOMM) trial 1 as a screening measure for insufficient effort.
    O'Bryant SE; Engel LR; Kleiner JS; Vasterling JJ; Black FW
    Clin Neuropsychol; 2007 May; 21(3):511-21. PubMed ID: 17455034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Welcoming a paradigm shift in occupational therapy: symptom validity measures and cognitive assessment.
    Fleming A; Rucas K
    Appl Neuropsychol Adult; 2015; 22(1):23-31. PubMed ID: 25529588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of somatoform symptomatology on credibility of cognitive performance.
    Boone KB; Lu PH
    Clin Neuropsychol; 1999 Nov; 13(4):414-9. PubMed ID: 10806453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conducting research with non-clinical healthy undergraduates: does effort play a role in neuropsychological test performance?
    An KY; Zakzanis KK; Joordens S
    Arch Clin Neuropsychol; 2012 Dec; 27(8):849-57. PubMed ID: 23027440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor symptom and performance validity in regularly referred Hospital outpatients: Link with standard clinical measures, and role of incentives.
    Dandachi-FitzGerald B; van Twillert B; van de Sande P; van Os Y; Ponds RW
    Psychiatry Res; 2016 May; 239():47-53. PubMed ID: 27137961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non-psychotic psychiatric populations.
    Schroeder RW; Marshall PS
    Clin Neuropsychol; 2011 Apr; 25(3):437-53. PubMed ID: 21391153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.